• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Enhancement by LDL of transfer of L-4F and oxidized lipids to HDL in C57BL/6J mice and human plasma.LDL 增强 C57BL/6J 小鼠和人血浆中 L-4F 和氧化脂质向 HDL 的转移。
J Lipid Res. 2011 Oct;52(10):1795-809. doi: 10.1194/jlr.M016741. Epub 2011 Jul 29.
2
An apoA-I mimetic peptide containing a proline residue has greater in vivo HDL binding and anti-inflammatory ability than the 4F peptide.含有脯氨酸残基的载脂蛋白 A-I 模拟肽比 4F 肽具有更强的体内 HDL 结合能力和抗炎能力。
J Lipid Res. 2009 Sep;50(9):1889-900. doi: 10.1194/jlr.M900151-JLR200. Epub 2009 May 11.
3
High-density lipoprotein and 4F peptide reduce systemic inflammation by modulating intestinal oxidized lipid metabolism: novel hypotheses and review of literature.高密度脂蛋白和 4F 肽通过调节肠道氧化脂质代谢来减轻全身炎症:新假说和文献综述。
Arterioscler Thromb Vasc Biol. 2012 Nov;32(11):2553-60. doi: 10.1161/ATVBAHA.112.300282.
4
Apolipoprotein A-I mimetic peptide helix number and helix linker influence potentially anti-atherogenic properties.载脂蛋白A-I模拟肽的螺旋数量和螺旋连接体影响潜在的抗动脉粥样硬化特性。
J Lipid Res. 2008 Jun;49(6):1268-83. doi: 10.1194/jlr.M700552-JLR200. Epub 2008 Mar 5.
5
The effect of HDL mimetic peptide 4F on PON1.载脂蛋白 1 对高密度脂蛋白模拟肽 4F 的影响。
Adv Exp Med Biol. 2010;660:167-72. doi: 10.1007/978-1-60761-350-3_15.
6
L-4F differentially alters plasma levels of oxidized fatty acids resulting in more anti-inflammatory HDL in mice.L-4F可不同程度地改变血浆中氧化脂肪酸的水平,从而在小鼠体内产生更多具有抗炎作用的高密度脂蛋白。
Drug Metab Lett. 2010 Aug;4(3):139-48. doi: 10.2174/187231210791698438.
7
Effects of D-4F on vasodilation and vessel wall thickness in hypercholesterolemic LDL receptor-null and LDL receptor/apolipoprotein A-I double-knockout mice on Western diet.D-4F对高脂饮食喂养的高胆固醇血症低密度脂蛋白受体缺失及低密度脂蛋白受体/载脂蛋白A-I双敲除小鼠血管舒张和血管壁厚度的影响。
Circ Res. 2005 Nov 25;97(11):1190-7. doi: 10.1161/01.RES.0000190634.60042.cb. Epub 2005 Oct 13.
8
In vitro stimulation of HDL anti-inflammatory activity and inhibition of LDL pro-inflammatory activity in the plasma of patients with end-stage renal disease by an apoA-1 mimetic peptide.载脂蛋白A-1模拟肽对终末期肾病患者血浆中高密度脂蛋白抗炎活性的体外刺激及低密度脂蛋白促炎活性的抑制作用
Kidney Int. 2009 Aug;76(4):437-44. doi: 10.1038/ki.2009.177. Epub 2009 May 27.
9
Apolipoprotein A-I mimetic peptides: a potential new therapy for the prevention of atherosclerosis.载脂蛋白 A-I 模拟肽:预防动脉粥样硬化的潜在新疗法。
Cardiol Rev. 2010 May-Jun;18(3):141-7. doi: 10.1097/CRD.0b013e3181c4b508.
10
A novel method for oral delivery of apolipoprotein mimetic peptides synthesized from all L-amino acids.一种由全L-氨基酸合成的载脂蛋白模拟肽口服递送的新方法。
J Lipid Res. 2009 Aug;50(8):1538-47. doi: 10.1194/jlr.M800539-JLR200. Epub 2009 Feb 18.

引用本文的文献

1
Nanodiscoidal Nucleic Acids for Gene Regulation.纳米盘状核酸用于基因调控。
ACS Chem Biol. 2023 Nov 17;18(11):2349-2367. doi: 10.1021/acschembio.3c00038. Epub 2023 Nov 1.
2
Post-Stroke Administration of L-4F Promotes Neurovascular and White Matter Remodeling in Type-2 Diabetic Stroke Mice.中风后给予L-4F可促进2型糖尿病中风小鼠的神经血管和白质重塑。
Front Neurol. 2022 Apr 28;13:863934. doi: 10.3389/fneur.2022.863934. eCollection 2022.
3
Apolipoprotein A-I mimetics mitigate intestinal inflammation in COX2-dependent inflammatory bowel disease model.载脂蛋白 A-I 模拟物可减轻 COX2 依赖性炎症性肠病模型中的肠道炎症。
J Clin Invest. 2019 Jun 11;129(9):3670-3685. doi: 10.1172/JCI123700.
4
ApoA-I mimetic administration, but not increased apoA-I-containing HDL, inhibits tumour growth in a mouse model of inherited breast cancer.载脂蛋白 A-I 模拟物给药,而不是增加载脂蛋白 A-I 含量的高密度脂蛋白,可抑制遗传性乳腺癌小鼠模型中的肿瘤生长。
Sci Rep. 2016 Nov 3;6:36387. doi: 10.1038/srep36387.
5
Transintestinal transport of the anti-inflammatory drug 4F and the modulation of transintestinal cholesterol efflux.抗炎药物4F的经肠转运及经肠胆固醇流出的调节
J Lipid Res. 2016 Jul;57(7):1175-93. doi: 10.1194/jlr.M067025. Epub 2016 May 19.
6
High-density lipoprotein mimetics: promises and challenges.高密度脂蛋白模拟物:前景与挑战。
Biochem J. 2015 Dec 15;472(3):249-59. doi: 10.1042/BJ20150832.
7
Apolipoprotein A-I mimetic peptide 4F blocks sphingomyelinase-induced LDL aggregation.载脂蛋白A-I模拟肽4F可阻止鞘磷脂酶诱导的低密度脂蛋白聚集。
J Lipid Res. 2015 Jun;56(6):1206-21. doi: 10.1194/jlr.M059485. Epub 2015 Apr 10.
8
L-4F inhibits lipopolysaccharide-mediated activation of primary human neutrophils.L-4F抑制脂多糖介导的原代人中性粒细胞的激活。
Inflammation. 2014 Oct;37(5):1401-12. doi: 10.1007/s10753-014-9864-7.
9
An apolipoprotein A-I mimetic peptide designed with a reductionist approach stimulates reverse cholesterol transport and reduces atherosclerosis in mice.一种采用简约主义方法设计的载脂蛋白 A-I 模拟肽可刺激胆固醇逆向转运并减少小鼠的动脉粥样硬化。
PLoS One. 2013 Jul 9;8(7):e68802. doi: 10.1371/journal.pone.0068802. Print 2013.
10
A mechanistic paradigm for broad-spectrum antivirals that target virus-cell fusion.一种针对病毒-细胞融合的广谱抗病毒药物的机制范例。
PLoS Pathog. 2013;9(4):e1003297. doi: 10.1371/journal.ppat.1003297. Epub 2013 Apr 18.

本文引用的文献

1
Intestine may be a major site of action for the apoA-I mimetic peptide 4F whether administered subcutaneously or orally.肠可能是载脂蛋白 A-I 模拟肽 4F 发挥作用的主要部位,无论其是经皮下给药还是口服给药。
J Lipid Res. 2011 Jun;52(6):1200-1210. doi: 10.1194/jlr.M013144. Epub 2011 Mar 28.
2
Treatment of patients with cardiovascular disease with L-4F, an apo-A1 mimetic, did not improve select biomarkers of HDL function.用 L-4F(一种载脂蛋白 A1 模拟物)治疗心血管疾病患者并没有改善 HDL 功能的某些生物标志物。
J Lipid Res. 2011 Feb;52(2):361-73. doi: 10.1194/jlr.M011098. Epub 2010 Nov 10.
3
Apolipoprotein A-I (apoA-I) and apoA-I mimetic peptides inhibit tumor development in a mouse model of ovarian cancer.载脂蛋白 A-I(apoA-I)和载脂蛋白 A-I 模拟肽可抑制卵巢癌小鼠模型中的肿瘤发展。
Proc Natl Acad Sci U S A. 2010 Nov 16;107(46):19997-20002. doi: 10.1073/pnas.1009010107. Epub 2010 Nov 1.
4
Apolipoprotein A-I mimetic peptides prevent atherosclerosis development and reduce plaque inflammation in a murine model of diabetes.载脂蛋白 A-I 模拟肽可预防糖尿病小鼠动脉粥样硬化的发展并减少斑块炎症。
Diabetes. 2010 Dec;59(12):3223-8. doi: 10.2337/db10-0844. Epub 2010 Sep 8.
5
L-4F differentially alters plasma levels of oxidized fatty acids resulting in more anti-inflammatory HDL in mice.L-4F可不同程度地改变血浆中氧化脂肪酸的水平,从而在小鼠体内产生更多具有抗炎作用的高密度脂蛋白。
Drug Metab Lett. 2010 Aug;4(3):139-48. doi: 10.2174/187231210791698438.
6
Chronic inflammation and mutagenesis.慢性炎症与突变。
Mutat Res. 2010 Aug 7;690(1-2):3-11. doi: 10.1016/j.mrfmmm.2010.03.007. Epub 2010 Mar 17.
7
Structure and function of HDL mimetics.高密度脂蛋白类似物的结构与功能。
Arterioscler Thromb Vasc Biol. 2010 Feb;30(2):164-8. doi: 10.1161/ATVBAHA.109.187518. Epub 2009 Jul 16.
8
Anti-inflammatory peptides grab on to the whiskers of atherogenic oxidized lipids.抗炎肽附着在致动脉粥样硬化的氧化脂质的“须状物”上。
Biochim Biophys Acta. 2009 Sep;1788(9):1967-75. doi: 10.1016/j.bbamem.2009.06.015. Epub 2009 Jun 25.
9
An apoA-I mimetic peptide containing a proline residue has greater in vivo HDL binding and anti-inflammatory ability than the 4F peptide.含有脯氨酸残基的载脂蛋白 A-I 模拟肽比 4F 肽具有更强的体内 HDL 结合能力和抗炎能力。
J Lipid Res. 2009 Sep;50(9):1889-900. doi: 10.1194/jlr.M900151-JLR200. Epub 2009 May 11.
10
Apoprotein A-I mimetic peptides and their potential anti-atherogenic mechanisms of action.载脂蛋白A-I模拟肽及其潜在的抗动脉粥样硬化作用机制。
Curr Opin Lipidol. 2009 Jun;20(3):171-5. doi: 10.1097/MOL.0b013e32832ac051.

LDL 增强 C57BL/6J 小鼠和人血浆中 L-4F 和氧化脂质向 HDL 的转移。

Enhancement by LDL of transfer of L-4F and oxidized lipids to HDL in C57BL/6J mice and human plasma.

机构信息

Department of Obstetrics and Gynecology, University of California Los Angeles, Los Angeles, CA, USA.

出版信息

J Lipid Res. 2011 Oct;52(10):1795-809. doi: 10.1194/jlr.M016741. Epub 2011 Jul 29.

DOI:10.1194/jlr.M016741
PMID:21804067
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3173006/
Abstract

The apoA-I mimetic peptide L-4F [(Ac-D-W-F-K-A-F-Y-D-K-V-A-E-K-F-K-E-A-F-NH2) synthesized from all L-amino acids] has shown potential for the treatment of a variety of diseases. Here, we demonstrate that LDL promotes association between L-4F and HDL. A 2- to 3-fold greater association of L-4F with human HDL was observed in the presence of human LDL as compared with HDL by itself. This association further increased when LDL was supplemented with the oxidized lipid 15S-hydroxy-5Z, 8Z, 11Z, 13E-eicosatetraenoic acid (15HETE). Additionally, L-4F significantly (P = 0.02) promoted the transfer of 15HETE from LDL to HDL. The transfer of L-4F from LDL to HDL was demonstrated both in vitro and in C57BL/6J mice. L-4F, injected into C57BL/6J mice, associated rapidly with HDL and was then cleared quickly from the circulation. Similarly, L-4F loaded onto human HDL and injected into C57BL/6J mice was cleared quickly with T(1/2) = 23.6 min. This was accompanied by a decline in human apoA-I with little or no effect on the mouse apoA-I. Based on these results, we propose that i) LDL promotes the association of L-4F with HDL and ii) in the presence of L-4F, oxidized lipids in LDL are rapidly transferred to HDL allowing these oxidized lipids to be acted upon by HDL-associated enzymes and/or cleared from the circulation.

摘要

载脂蛋白 A-I 模拟肽 L-4F(由全 L-氨基酸合成,Ac-D-W-F-K-A-F-Y-D-K-V-A-E-K-F-K-E-A-F-NH2)在治疗多种疾病方面显示出潜力。在这里,我们证明 LDL 促进 L-4F 与 HDL 的结合。与单独的 HDL 相比,在存在人 LDL 的情况下,L-4F 与人 HDL 的结合增加了 2-3 倍。当 LDL 补充氧化脂质 15S-羟基-5Z、8Z、11Z、13E-二十碳四烯酸(15HETE)时,这种结合进一步增加。此外,L-4F 显著(P = 0.02)促进了 15HETE 从 LDL 向 HDL 的转移。在体外和 C57BL/6J 小鼠中均证明了 L-4F 从 LDL 向 HDL 的转移。L-4F 注射到 C57BL/6J 小鼠中,与 HDL 迅速结合,然后很快从循环中清除。同样,加载到人 HDL 上并注射到 C57BL/6J 小鼠中的 L-4F 也很快被清除,T1/2 = 23.6 分钟。这伴随着人载脂蛋白 A-I 的下降,而对小鼠载脂蛋白 A-I 几乎没有影响。基于这些结果,我们提出以下假设:i)LDL 促进 L-4F 与 HDL 的结合,ii)在 L-4F 存在的情况下,LDL 中的氧化脂质迅速转移到 HDL 中,使这些氧化脂质能够被 HDL 相关酶作用或从循环中清除。